Abstract
This study comprises 120 full-term infants with AB0 hemolytic disease admitted to the neonatal department during a period of 60 months from 1970 to 1975. During the first 30 months newborns (n=61) received no D-penicillamine therapy, whereas all infants (n=59) received this treatment (300–400 mg/kg/day, divided into 4 equal doses, for 2–5 days) during the last 30 months. The patients were further subdivided into two groups according to the point of time when D-penicillamine treatment was begun, viz. group I (34 treated and 34 control infants) within the first 24 h of life; group II (25 treated and 27 control infants) after the third day of life. In group I D-penicillamine therapy caused a marked decline of serum bilirubin concentrations at a time when such levels were rising in the control infants. The number of exchange transfusions per infant was 1.32 in the control and 0.11 in the D-penicillamine-treated infants.
In group II D-penicillamine considerably reduced the number of exchange transfusions (0.70∶0.24=control∶treated) but the difference was statistically not significant. In the latter patients the mean bilirubin values showed a smaller difference compared to the controls than in group I.
Since group I represented the results of early or preventive treatment, while group II those of late or therapeutic treatment, it is obvious that, for ensuring success, D-penicillamine treatment should be begun as early as possible in AB0 hemolytic disease of the newborn.
Similar content being viewed by others
References
Gros, H., Zwirner, K.: Die Behandlung der chronisch-aggressiven Hepatitis mit D-Penicillamin. Med. Klin. 69, 333 (1974)
Haas, P., Wendt, H.: Nephrotisches Syndrom und Schilddrüsenschwellung nach D-Penicillamin. Wien. med. Wschr. 124, 333 (1974)
Hennemann, H. H., Hubertus, H., Stocker, W. G.: Schwere Nebenwirkungen bei der Therapie mit D-Penicillamin. Dtsch. med. Wschr. 100, 1634 (1975)
Henningsen, B. J., Maintz, H., Basedow, M., Harders, H.: Nephrotisches Syndrom durch Penicillamin. Dtsch. med. Wschr. 98, 1768 (1973)
Jezerniczky, J.: A simple ultramicromethod for indirect serum bilirubin determination. Acta paediat. Acad. Sci. hung. 13, 239 (1972)
Lakatos, L., Kövér, B.: D-penicillamine treatment in neonatal hyperbilirubinemia. Previous report. Orv. Hetil. (hung.) 115, 307 (1974)
Lakatos, L., Kövér, B., Péter, F.: D-penicillamine therapy of neonatal hyperbilirubinaemia. Acta paediat. Acad. Sci. hung. 15, 77 (1974)
Lakatos, L., Kövér, B., Dvoracsek, É., Vekerdy, Zs.: D-penicillamine treatment of the hemolytic disease of the newborn and neonatal hyperbilirubinemic. Orv. Hetil. (hung.) 116, 1863 (1975)
Lakatos, L., Kövér, B., Vekerdy, Zs., Dvoracsek, É.: D-penicillamine therapy in neonatal jaundice: comparison with phototherapy. Acta paediat. Acad. Sci. hung. (in press)
Mertz, J. E., West, C. D.: A rapid micromethod for the determination of indirect bilirubin. Amer. J. Dis. Child. 91, 19 (1956)
Perings, E., Junge, U.: Wirkungen und Nebenwirkungen von D-Penicillamin. Med. Klin. 70, 1265 (1975)
Schellong, G.: Untersuchungen über die Brauchbarkeit des Polacek Diagramma für die Indikation zur Austauschtransfusion. Mschr. Kinderheilk. 115, 1 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lakatos, L., Kövér, B., Oroszlán, G. et al. D-penicillamine therapy in AB0 hemolytic disease of the newborn infant. Eur J Pediatr 123, 133–137 (1976). https://doi.org/10.1007/BF00442643
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00442643